NCT02326103View on ClinicalTrials.gov

Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Alcoholic HepatitisAlcoholic Cirrhosis
Interventions
DRUG

Ciprofloxacin

Comparison of ciprofloxacin with placebo in alcoholic hepatitis

DRUG

Placebo

Trial Locations (1)

00029HUS

University Hospital of Helsinki, Helsinki

All Listed Sponsors
lead

University of Helsinki

OTHER

NCT02326103 - Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis | Biotech Hunter | Biotech Hunter